SEC Form 4 research
| Issuer | ContraVir Pharmaceuticals, Inc. |
|---|---|
| Tickers | CTRV, HEPA |
| Reporting owners | 30 |
| Officers and directors | 10 |
| Last public filing | 2026-10-27 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-27 | 2026-10-23 | Liddy James Gordon | A | 510,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Fisher Danina | A | 510,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Stetz Gary S. | A | 1,530,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | LoPriore Vincent S | A | 1,530,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Purcell Michael J. | A | 510,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Appajosyula Sireesh | A | 1,530,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | LoPriore Chase | A | 1,530,000 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Stetz Gary S. II | A | 510,000 | $0 | Not reported |
| 2026-10-02 | 2026-09-29 | Fisher Danina | P | 200,000 | $0.05 | Not reported |
| 2026-10-02 | 2026-09-29 | Fisher Danina | P | 200,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.